Newton, K. & Dixit, V. M. Signaling in innate immunity and inflammation. Cold Spring Harb. Perspect. Biol. 4, a006049 (2012).

Article  PubMed  PubMed Central  Google Scholar 

Meissner, F., Scheltema, R. A., Mollenkopf, H. J. & Mann, M. Direct proteomic quantification of the secretome of activated immune cells. Science 340, 475–478 (2013).

Article  CAS  PubMed  Google Scholar 

Broz, P. & Dixit, V. M. Inflammasomes: mechanism of assembly, regulation and signalling. Nat. Rev. Immunol. 16, 407–420 (2016).

Article  CAS  PubMed  Google Scholar 

Lamkanfi, M. & Dixit, V. M. Mechanisms and functions of inflammasomes. Cell 157, 1013–1022 (2014).

Article  CAS  PubMed  Google Scholar 

Paerewijck, O. & Lamkanfi, M. The human inflammasomes. Mol. Asp. Med. 88, 101100 (2022).

Article  CAS  Google Scholar 

Kayagaki, N. et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 526, 666–671 (2015). This report describes the identification of GSDMD as an essential effector of pyroptosis and IL-1β release.

Article  CAS  PubMed  Google Scholar 

Shi, J. et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526, 660–665 (2015). This report describes the identification of GSDMD as an essential effector of pyroptosis and IL-1β release.

Article  CAS  PubMed  Google Scholar 

He, W. T. et al. Gasdermin D is an executor of pyroptosis and required for interleukin-1beta secretion. Cell Res. 25, 1285–1298 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aglietti, R. A. et al. GsdmD p30 elicited by caspase-11 during pyroptosis forms pores in membranes. Proc. Natl Acad. Sci. USA 113, 7858–7863 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ding, J. et al. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature 535, 111–116 (2016).

Article  CAS  PubMed  Google Scholar 

Liu, X. et al. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature 535, 153–158 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sborgi, L. et al. GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death. EMBO J. 35, 1766–1778 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lamkanfi, M. et al. Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia. J. Immunol. 185, 4385–4392 (2010).

Article  CAS  PubMed  Google Scholar 

Kayagaki, N. et al. NINJ1 mediates plasma membrane rupture during lytic cell death. Nature 591, 131–136 (2021). This paper demonstrates that pyroptotic cell lysis is a controlled event regulated by NINJ1.

Article  CAS  PubMed  Google Scholar 

Nadkarni, R. et al. Viral proteases activate the CARD8 inflammasome in the human cardiovascular system. J. Exp. Med. 219, e0212117 (2022).

Article  Google Scholar 

Su, S. et al. Immune checkpoint inhibition overcomes ADCP-induced immunosuppression by macrophages. Cell 175, 442–457 e423 (2018).

Article  CAS  PubMed  Google Scholar 

Kumari, P., Russo, A. J., Shivcharan, S. & Rathinam, V. A. AIM2 in health and disease: inflammasome and beyond. Immunol. Rev. 297, 83–95 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fidler, T. P. et al. The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis. Nature 592, 296–301 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou, J. Y. et al. Activation of the NLRP1 inflammasome in human keratinocytes by the dsDNA mimetic poly(dA:dT). Proc. Natl Acad. Sci. USA 120, e2213777120 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gaidt, M. M. et al. The DNA inflammasome in human myeloid cells is initiated by a STING-cell death program upstream of NLRP3. Cell 171, 1110–1124 e1118 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Munoz-Planillo, R. et al. K+ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38, 1142–1153 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gross, C. J. et al. K+ efflux-independent NLRP3 inflammasome activation by small molecules targeting mitochondria. Immunity 45, 761–773 (2016).

Article  CAS  PubMed  Google Scholar 

Gaidt, M. M. et al. Human monocytes engage an alternative inflammasome pathway. Immunity 44, 833–846 (2016).

Article  CAS  PubMed  Google Scholar 

Bauernfeind, F. G. et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 183, 787–791 (2009).

Article  CAS  PubMed  Google Scholar 

McKee, C. M. & Coll, R. C. NLRP3 inflammasome priming: a riddle wrapped in a mystery inside an enigma. J. Leukoc. Biol. 108, 937–952 (2020).

Article  CAS  PubMed  Google Scholar 

He, Y., Zeng, M. Y., Yang, D., Motro, B. & Nunez, G. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature 530, 354–357 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi, H. et al. NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component. Nat. Immunol. 17, 250–258 (2016).

Article  CAS  PubMed  Google Scholar 

Schmid-Burgk, J. L. et al. A genome-wide CRISPR (clustered regularly interspaced short palindromic repeats) screen identifies NEK7 as an essential component of NLRP3 inflammasome activation. J. Biol. Chem. 291, 103–109 (2016).

Article  CAS  PubMed  Google Scholar 

Netea, M. G. et al. Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 113, 2324–2335 (2009).

Article  CAS  PubMed  PubMed Central  Google Scholar 

O’Brien, M. et al. A bioluminescent caspase-1 activity assay rapidly monitors inflammasome activation in cells. J. Immunol. methods 447, 1–13 (2017).

Article  PubMed  Google Scholar 

Santos, J. C. et al. Human GBP1 binds LPS to initiate assembly of a caspase-4 activating platform on cytosolic bacteria. Nat. Commun. 11, 3276 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi, J. et al. Inflammatory caspases are innate immune receptors for intracellular LPS. Nature 514, 187–192 (2014).

Article  CAS  PubMed  Google Scholar 

Kayagaki, N. et al. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science 341, 1246–1249 (2013).

Article  CAS  PubMed  Google Scholar 

Knodler, L. A. et al. Noncanonical inflammasome activation of caspase-4/caspase-11 mediates epithelial defenses against enteric bacterial pathogens. Cell Host Microbe 16, 249–256 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Andreeva, L. et al. NLRP3 cages revealed by full-length mouse NLRP3 structure control pathway activation. Cell 184, 6299–6312 e6222 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dekker, C. et al. Crystal structure of NLRP3 NACHT domain with an inhibitor defines mechanism of inflammasome inhibition. J. Mol. Biol. 433, 167309 (2021).

Article  CAS  PubMed  Google Scholar 

Hochheiser, I. V. et al. Structure of the NLRP3 decamer bound to the cytokine release inhibitor CRID3. Nature 604, 184–189 (2022). Report of a cryo-EM structure of full-length human NLRP3 bound to an NLRP3 inhibitor.

Article  CAS  PubMed